In, Gino K. http://orcid.org/0000-0002-7060-5123
Ribeiro, Jennifer R. http://orcid.org/0000-0002-1685-8568
Yin, Jun
Xiu, Joanne
Bustos, Matias A.
Ito, Fumito
Chow, Frances http://orcid.org/0000-0001-5402-2473
Zada, Gabriel
Hwang, Lindsay
Salama, April K. S.
Park, Soo J.
Moser, Justin C.
Darabi, Sourat http://orcid.org/0000-0002-3395-894X
Domingo-Musibay, Evidio http://orcid.org/0000-0002-2082-554X
Ascierto, Maria L.
Margolin, Kim
Lutzky, Jose
Gibney, Geoffrey T.
Atkins, Michael B. http://orcid.org/0000-0003-3901-9924
Izar, Benjamin http://orcid.org/0000-0003-2379-6702
Hoon, Dave S. B. http://orcid.org/0000-0003-1915-3683
VanderWalde, Ari M.
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (P30 CA014089, R01CA255240-01A1)
U.S. Department of Health & Human Services | National Institutes of Health
Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
Article History
Received: 17 May 2023
Accepted: 24 October 2023
First Online: 14 November 2023
Competing interests
: G.K.I.: Research funding (paid to institution): Regeneron, Array, Idera, Genentech, Replimune, Xencor, InstilBio, Pfizer, Checkmate Pharmaceuticals; Consulting or Advisory role: Bristol Myers Squibb, Regeneron, Sanofi, Replimune, Pfizer, Novartis. J.Y., J.X., J.R.R., and A.M.V.: employees of Caris Life Sciences. S.D.: Oncolens, Bayer, and BostonGene. A.K.S.S.: Research funding (paid to institution): Ascentage, Bristol Myers Squibb, Ideaya, Immunocore, Merck, Olatec Therapeutics, Regeneron, Replimune, Seagen; consultant or advisory role: Bristol Myers Squibb, Iovance, Regeneron, Replimune, Novartis, Pfizer. J.C.M.: Research funding (paid to institution): NovoCure (Inst), Genentech, Alpine Immune Sciences, Amgen, Trishula Therapeutics, BioEclipse Therapeutics, FujiFilm, ImmuneSensor, Simcha, Repertoire Immune Sciences, Nektar Therapeutics, Synthorx Inc, Istari Oncology, Ideaya Biosciences, Rubius, University of Arizona, Senwha, Storm Therapeutics, Werewolf Therapeutics, Fate Therapeutics, Y-Mab, Agenus; consultant or advisory role: BMS, Amunix, Thirona Bio, Adagene, Imaging Endpoints, Boxer Capitol, Oberland Capital, IQVIA, Caris Life Sciences, Genome Insight; speakers Bureau: Caris Life Sciences, Immunocore. S.J.P.: Advisory role: Regeneron. B.I.: Consulting fees/honoraria: Volastra Therapeutics Inc, Merck, AstraZeneca, Eisai and Janssen Pharmaceuticals; research funding (paid to institution): Agenus, Alkermes, Arcus Biosciences, Checkmate Pharmaceuticals, Compugen, Immunocore, and Synthekine.